Synthon contracts Antitope for ADC testing

- Last updated on GMT

Related tags: Immunology, Immune system, Cancer

Synthon contracts Antitope for ADC testing
Synthon has called on UK immunogenicity testing firm Antitope to analyze its pipeline of antibody drug conjugate (ADC) candidates.

The Antitope EpiScreen platform consists of pooled peripheral mononuclear blood cells (PMBCs) derived from multiple donors which, when exposed to drug candidates, exhibit a measurable immune response.

The aim of the deal is to determine the immunogenicity of the antibody part of the ADCs according to Synthon CSO, Marco Timmers, who said the tech will “reduce the risk that Synthon's antibody based development candidates will induce immunogenic responses​.”

Synthon’s ADC programme – which is based the manufacturing facility it opened in Nijmegen, the Netherlands in 2013 – is focused on breast cancer tumours that over-express the protein marker HER2.

The collaboration follows weeks after Antitope was called in to develop a manufacturing cell line for a novel dendritic-cell-targeting vaccine for the treatment of head and neck and cervical cancer being developed by the Baylor Institute for Immunology Research (BIIR).

It also follows a string of biopharmaceutical collaborations agreed by Antitope’s parent company Abzena, including the deal signed by its other subsidiary Polytherics and developer Macrogenics in April.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us

Products

View more

Webinars